Obeticholic Acid for Prevention in Barrett's Esophagus

NCT04939051 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

NIH

Sponsor class

Conditions

Barrett Esophagus
Esophageal Adenocarcinoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Esophageal Biopsy
PROCEDURE: Esophagogastroduodenoscopy
PROCEDURE: Liver Ultrasonographic Elastography
BIOLOGICAL: Obeticholic Acid
DRUG: Placebo Administration
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)